MPM Asset Management’s Aratana Therapeutics, Inc. PETX Stock Holding History

MPM Asset Management’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-250,000	Closed	-$900K	–	7
2019 Q1	$900K	Hold	250,000	–	–	0.37%	7
2018 Q4	$1.53M	Hold	250,000	–	–	1.3%	6
2018 Q3	$1.46M	Hold	250,000	–	–	0.99%	7
2018 Q2	$1.06M	Hold	250,000	–	–	0.41%	8
2018 Q1	$1.1M	Hold	250,000	–	–	0.42%	8
2017 Q4	$1.31M	Hold	250,000	–	–	0.53%	8
2017 Q3	$1.53M	Hold	250,000	–	–	0.75%	7
2017 Q2	$1.81M	Hold	250,000	–	–	0.79%	6
2017 Q1	$1.32M	Hold	250,000	–	–	0.64%	7
2016 Q4	$1.79M	Hold	250,000	–	–	0.85%	8
2016 Q3	$2.34M	Sell	250,000 -867,875	-78%	-$7.21M	0.77%	8
2016 Q2	$7.07M	Hold	1,117,875	–	–	2.29%	7
2016 Q1	$6.17M	Hold	1,117,875	–	–	1.91%	8
2015 Q4	$6.24M	Hold	1,117,875	–	–	1.11%	8
2015 Q3	$9.46M	Sell	1,117,875 -1,000,970	-47%	-$16.9M	1.45%	7
2015 Q2	$32M	Hold	2,118,845	–	–	5.36%	4
2015 Q1	$33.9M	Hold	2,118,845	–	–	7.23%	4
2014 Q4	$37.8M	Hold	2,118,845	–	–	8.39%	3
2014 Q3	$21.3M	Buy	2,118,845 +25,000	+1%	+$303K	6.96%	5
2014 Q2	$32.7M	Sell	2,093,845 -694,320	-25%	-$9.84M	11%	4
2014 Q1	$51.7M	Sell	2,788,165 -1,562,883	-36%	-$31.3M	21.9%	2
2013 Q4	$83.1M	Hold	4,351,048	–	–	26.84%	1
2013 Q3	$71.1M	Buy	4,351,048 +4,170,543	+2,310%	+$43.8M	20.05%	2
2013 Q2	$1.36M	Buy	+180,505	New	+$1.43M	0.6%	10

Other funds holding PETX

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

WIC

Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OAC

OMERS Administration Corp Toronto, Ontario, Canada $16.7B AUM 35.96% 1-Year Est. Return

MPM Asset Management's PETX Position: Q2 2019 in Review

MPM Asset Management sold out of Aratana Therapeutics, Inc. (PETX) in Q2 2019, closing a stake of 250,000 shares — an estimated $900K sold.

MPM Asset Management first reported a position in PETX in Q2 2013 and held it in 24 quarters. The position peaked at $83.1M in Q4 2013. 103 funds tracked by Wall St. Rank hold PETX as of Q2 2019.

MPM Asset Management reported no remaining Aratana Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
MPM Asset Management sold 250,000 Aratana Therapeutics, Inc. shares in Q2 2019, an estimated $900K.
MPM Asset Management first reported a position in Aratana Therapeutics, Inc. in Q2 2013 and held it in 24 quarters.
MPM Asset Management's Aratana Therapeutics, Inc. position peaked at $83.1M in Q4 2013.
103 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q2 2019.

Based on MPM Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.